This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas F. Imperiale, MD; Theodore Speroff, PhD

JAMA. 1994;271(22):1780-1785.

Abstract
Objective.
—While several methods of prophylaxis have been shown to reduce the risk of venous thromboembolism following total hip replacement, the safest and most effective agent is unclear. To clarify this issue, we performed a meta-analysis of the randomized trials of methods used to prevent venous thromboembolism following total hip replacement.

Data Source.
—English-language human studies articles from 1966 through 1993 were obtained from a MEDLINE database search with indexing terms including thromboembolism, hip replacement or hip prosthesis, and randomized controlled trials. Additional references were obtained from study bibliographies.

Study Selection.
—The following criteria were used to select studies for inclusion: study design—randomized clinical trial; study population—patients undergoing elective total hip replacement; interventions—aspirin, warfarin, dextran, heparin, low-molecular-weight heparin, compression stockings; and outcomes— venous thromboembolism, major hemorrhage.

Data Extraction.
—Methodological and descriptive data from each study were abstracted by one author who was blinded to quantitative outcomes data.

Data Synthesis.
—Ninety-one treatment groups and 25 control groups were identified from 56 trials. Four treatment groups were excluded because of rarely used combinations. Trial populations were clinically homogeneous. When compared with the control arm, all treatments except aspirin reduced the risk of all deep venous thromboses (risk differences range, 0.18 to 0.31; all P values <.05). All treatments except aspirin reduced the risk of proximal venous thrombosis (risk differences range, 0.09 to 0.18; all P values <.05). Only low-molecular-weight heparin and stockings reduced the risk of pulmonary embolism, both with risk differences equal to 0.02. The crude risks of clinically important bleeding as defined by the individual trials were 0% for stockings, 0.3% for controls, and 1.8% for low-molecular-weight heparin.

Conclusions.
—The results suggest that low-molecular-weight heparin and compression stockings have the greatest relative efficacy in preventing venous thromboembolism following total hip replacement. Low-molecular-weight heparin may be more effective, though at a small risk of clinically important bleeding.

(JAMA. 1994;271:1780-1785)

Author Affiliations
From the Divisions of General Medicine and Gastroenterology, Department of Medicine (Dr Imperiale), and the Department of Epidemiology and Biostatistics (Dr Speroff), Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio.

Footnotes
Presented in part at the 14th annual meeting of the Society for Medical Decision Making, Portland, Ore, October 20, 1992.

Reprint requests to the Department of Medicine, MetroHealth Medical Center, 2500 MetroHealth Dr, Room W603, Cleveland, OH 44109-1998 (Dr Imperiale).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty
Johanson et al.
J Am Acad Orthop Surg 2009;17:183-196.
ABSTRACT | FULL TEXT  

IN REPLY
DEITELZWEIG et al.
Cleveland Clinic Journal of Medicine 2008;75:472-473.
FULL TEXT  

Multimodal thromboprophylaxis following primary hip arthroplasty: THE ROLE OF ADJUVANT INTERMITTENT PNEUMATIC CALF COMPRESSION
Daniel et al.
J Bone Joint Surg Br 2008;90-B:562-569.
ABSTRACT | FULL TEXT  

Multimodal Thromboprophylaxis for Total Hip and Knee Arthroplasty Based on Risk Assessment
Dorr et al.
JBJS 2007;89:2648-2657.
ABSTRACT | FULL TEXT  

Estimated Annual Costs of Prophylaxis and Treatment of Venous Thromboembolic Events Associated With Major Orthopedic Surgery in France
Tilleul et al.
CLIN APPL THROMB HEMOST 2006;12:473-484.
ABSTRACT  

The outcome of total hip replacement in obese and non-obese patients at 10- to 18-years
McLaughlin and Lee
J Bone Joint Surg Br 2006;88-B:1286-1292.
ABSTRACT | FULL TEXT  

Venous thromboembolism associated with hip and knee replacement over a ten-year period: A POPULATION-BASED STUDY
Howie et al.
J Bone Joint Surg Br 2005;87-B:1675-1680.
ABSTRACT | FULL TEXT  

Deep vein thrombosis after total hip and knee arthroplasty in Indian patients
Jain et al.
Postgrad. Med. J. 2004;80:729-731.
ABSTRACT | FULL TEXT  

Venous Thrombosis After Hallux Valgus Surgery
Radl et al.
JBJS 2003;85:1204-1208.
ABSTRACT | FULL TEXT  

Arthroscopic Anterior Cruciate Ligament Reconstruction: A Metaanalysis Comparing Patellar Tendon and Hamstring Tendon Autografts
Freedman et al.
Am J Sports Med 2003;31:2-11.
ABSTRACT | FULL TEXT  

Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery: A Meta-analysis of 4 Randomized Double-blind Studies
Turpie et al.
Arch Intern Med 2002;162:1833-1840.
ABSTRACT | FULL TEXT  

Prophylaxis Against Venous Thromboembolic Disease in Patients Having a Total Hip or Knee Arthroplasty
Sculco et al.
JBJS 2002;84:466-477.
FULL TEXT  

Prophylaxis Against Fat and Bone-Marrow Embolism During Total Hip Arthroplasty Reduces the Incidence of Postoperative Deep-Vein Thrombosis : A Controlled, Randomized Clinical Trial
Pitto et al.
JBJS 2002;84:39-48.
ABSTRACT | FULL TEXT  

Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement
Bell and Goldhaber
Vasc Med 2001;6:23-29.
ABSTRACT  

Prevention of Venous Thromboembolism
Geerts et al.
Chest 2001;119 :132S-175S.
FULL TEXT  

Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip Arthroplasty
White et al.
NEJM 2000;343:1758-1764.
ABSTRACT | FULL TEXT  

A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty
Freedman et al.
JBJS 2000;82:929-929.
ABSTRACT | FULL TEXT  

Symposium - Recent Advances in Venous Thromboembolic Prophylaxis During and After Total Hip Replacement
SALVATI et al.
JBJS 2000;82:252-70.
FULL TEXT  

Efficacy of Prophylaxis Against Thromboembolism with Intermittent Pneumatic Compression After Primary and Revision Total Hip Arthroplasty
HOOKER et al.
JBJS 1999;81:690-6.
ABSTRACT | FULL TEXT  

Thromboembolic Prophylaxis with Use of Aspirin, Exercise, and Graded Elastic Stockings or Intermittent Compression Devices in Patients Managed with Total Hip Arthroplasty
SARMIENTO and GOSWAMI
JBJS 1999;81:339-46.
ABSTRACT | FULL TEXT  

Prevention and treatment of venous thromboembolism after major trauma
Verstraete
Trauma 1999;1:39-51.
ABSTRACT  

Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
White et al.
Arch Intern Med 1998;158:1525-1531.
ABSTRACT | FULL TEXT  

Lesson of the week: Pneumatic compression boots for prophylaxis against deep vein thrombosis: beware occult arterial disease
Oakley et al.
BMJ 1998;316:454-455.
FULL TEXT  

Antithrombotic Agents and Thromboembolic Disease
Ewenstein
NEJM 1997;337:1383-1384.
FULL TEXT  

Detecting the effects of thromboprophylaxis: the case of the rogue reviews
Petticrew and Kennedy
BMJ 1997;315:665-668.
FULL TEXT  

Low-Molecular-Weight Heparins
Weitz
NEJM 1997;337:688-699.
FULL TEXT  

Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin
FRANCIS et al.
JBJS 1997;79:1365-72.
ABSTRACT | FULL TEXT  

Factor V Leiden: should we screen oral contraceptive users and pregnant women?
Vandenbroucke et al.
BMJ 1996;313:1127-1130.
FULL TEXT  

Intermittent Pneumatic Compression Prophylaxis for Proximal Deep Venous Thrombosis after Total Hip Replacement
WOOLSON
JBJS 1996;78:1735-40.
ABSTRACT | FULL TEXT  

A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma
Geerts et al.
NEJM 1996;335:701-707.
ABSTRACT | FULL TEXT  

Prophylaxis Against Venous Thromboembolism After Hip Surgery
Megerman
JAMA 1995;273:287-287.
ABSTRACT  

Prophylaxis Against Venous Thromboembolism After Hip Surgery
Chell et al.
JAMA 1995;273:287-288.
ABSTRACT